When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZGNX - FDA OKs Zogenix's Fintepla for Dravet syndrome
Zogenix Inc.
Under Priority Review status, the FDA has accepted Zogenix's (NASDAQ:ZGNX) NDA for FINTEPLA (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet syndrome.
More news on: Zogenix, Inc., Healthcare stocks news,